These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8723495)

  • 1. Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model.
    Barchiesi F; Najvar LK; Luther MF; Scalise G; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1996 May; 40(5):1317-20. PubMed ID: 8723495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection.
    Redding SW; Pfaller MA; Messer SA; Smith JA; Prows J; Bradley LL; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1997 Jul; 35(7):1761-5. PubMed ID: 9196188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.
    Pfaller MA; Rhine-Chalberg J; Redding SW; Smith J; Farinacci G; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1994 Jan; 32(1):59-64. PubMed ID: 7907345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
    Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
    J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
    White TC; Pfaller MA; Rinaldi MG; Smith J; Redding SW
    Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS.
    Vazquez JA; Zawawi AA
    HIV Clin Trials; 2002; 3(5):379-85. PubMed ID: 12407487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic dissimilarity of two fluconazole-resistant Candida albicans strains causing meningitis and oral candidiasis in the same AIDS patient.
    Berenguer J; Diaz-Guerra TM; Ruiz-Diez B; Bernaldo de Quiros JC; Rodriguez-Tudela JL; Martinez-Suarez JV
    J Clin Microbiol; 1996 Jun; 34(6):1542-5. PubMed ID: 8735114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates.
    Diaz-Guerra TM; Martinez-Suarez JV; Laguna F; Valencia E; Rodriguez-Tudela JL
    AIDS; 1998 Sep; 12(13):1601-10. PubMed ID: 9764778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS.
    Ruhnke M; Schmidt-Westhausen A; Morschhäuser J
    J Antimicrob Chemother; 2000 Aug; 46(2):291-5. PubMed ID: 10933656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
    Martínez M; López-Ribot JL; Kirkpatrick WR; Bachmann SP; Perea S; Ruesga MT; Patterson TF
    J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors.
    Lacassin F; Damond F; Chochillon C; Longuet P; Lebras J; Vilde JL; Leport C
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1961-3. PubMed ID: 8843316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
    J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
    Barchiesi F; Colombo AL; McGough DA; Fothergill AW; Rinaldi MG
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2553-6. PubMed ID: 7872746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low levels of antigenic variability in fluconazole-susceptible and -resistant Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Lopez-Ribot JL; McAtee RK; Kirkpatrick WR; La Valle R; Patterson TF
    Clin Diagn Lab Immunol; 1999 Sep; 6(5):665-70. PubMed ID: 10473514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS.
    Barchiesi F; Hollis RJ; McGough DA; Scalise G; Rinaldi MG; Pfaller MA
    Clin Infect Dis; 1995 Mar; 20(3):634-40. PubMed ID: 7756488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
    Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
    Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.